"Sulfonylurea Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D013453
|
| MeSH Number(s) |
D02.886.590.795 D02.948.828
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sulfonylurea Compounds".
Below are MeSH descriptors whose meaning is more specific than "Sulfonylurea Compounds".
This graph shows the total number of publications written about "Sulfonylurea Compounds" by people in this website by year, and whether "Sulfonylurea Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 10 | 8 | 18 |
| 2018 | 9 | 10 | 19 |
| 2019 | 6 | 3 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Sulfonylurea Compounds" by people in Profiles.
-
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor. Bioorg Med Chem Lett. 2020 11 01; 30(21):127571.
-
Dissecting the interaction between COVID-19 and diabetes mellitus. J Diabetes Investig. 2020 Sep; 11(5):1104-1114.
-
Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care. J Clin Endocrinol Metab. 2019 08 01; 104(8):3296-3302.
-
Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults With Incident Type 2 Diabetes. J Clin Endocrinol Metab. 2019 06 01; 104(6):1989-1998.
-
Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba castellanii. J Microbiol Biotechnol. 2019 May 28; 29(5):713-720.
-
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
-
Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015. Acta Diabetol. 2019 Aug; 56(8):889-897.
-
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes. Diabetes Metab. 2020 10; 46(5):409-411.
-
Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes Res Clin Pract. 2019 Apr; 150:331-341.
-
Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study. Acta Diabetol. 2019 May; 56(5):505-513.